# Hong Kong Zihua Pharmaceutical Ltd. – FDA Inspection, Sep 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/hong-kong-zihua-pharmaceutical-ltd/f9d0702f-919e-4506-b722-8158284a1718
Source feed: FDA_Inspections

> FDA inspection 1025270 of Hong Kong Zihua Pharmaceutical Ltd., September 15, 2017. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1025270
- Company Name: Hong Kong Zihua Pharmaceutical Ltd.
- Inspection Date: 2017-09-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/alice-s-tsao/b6d72ceb-de7c-413d-b104-cac3b075c170)

Company: https://www.keypedia.com/companies/hong-kong-zihua-pharmaceutical-ltd/f4157c96-eed2-437c-907c-f16abb8a4ed3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c